A case of nivolumab-induced cervical lymphadenopathy in a patient with gastric cancer

Nivolumab is a monoclonal antibody targeting programmed cell death-1 (PD-1) that has been recently shown to exhibit clinical efficacy in patients with gastric cancer. However, various degrees of immune-related adverse events (irAEs) have been reported. We report the case of a 71-year-old male patien...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Gastrointest Oncol
Autores principales: Taira, Koichi, Kimura, Akie, Nakata, Akinobu, Nadatani, Yuji, Fukunaga, Shusei, Otani, Koji, Hosomi, Shuhei, Tanaka, Fumio, Kamata, Noriko, Nagami, Yasuaki, Watanabe, Toshio, Fujiwara, Yasuhiro
Formato: Artigo
Lenguaje:Inglês
Publicado: AME Publishing Company 2021
Materias:
Case Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8107580/
https://ncbi.nlm.nih.gov/pubmed/34012675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-315
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares